Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease

神经退行性疾病新治疗策略的教师招聘

• 批准号: 7858933
• 负责人: RAYMOND J DINGLEDINE
• 金额: $ 63.75万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7858933
• 关键词: Faculty; Recruitment; Novel; Therapeutic; Strategies

DESCRIPTION (provided by applicant): This proposal seeks support for new faculty recruitment to chance research capacity at Emory University in the area of novel therapeutic strategies for neurodegenerative disease through the biomedical research core center (p30) mechanism. As the center director, Dr. Raymond Dingledine (Chairman and Professor of Pharmacology and the Executive Associate Dean for Research in the School of Medicine) will work with Drs. Allan Levey (Chairman and Professor of Neurology and Director of Center for Neurodegenerative Disease) and Lian Li (Vice Chair and Professor of Pharmacology) to recruit and mentor a highly motivated tenure- track Assistant Professor to conduct research focusing on the basic and/or translational studies of neurodegenerative disease, with relevance to the development of novel therapeutic strategies for combating neurodegeneration. The newly-recruited investigator will have primary appointment in the Department of Pharmacology and secondary appointments in the Department of Neurology and the Center for Neurodegenerative Disease. The core center will leverage generous institutional support for space, personnel, and other resources and provide an outstanding, collaborative, and interdisciplinary environment and a comprehensive, thorough, and rigorous faculty development and evaluation plan that foster independent research career and professional development of the new faculty member. Achieving the goals proposed in this application will augment and expand Emory's community of multidisciplinary researchers focusing on the basic, translational, and clinic studies of neurodegenerative diseases, establish and strengthen the intra-institutional relationships among various components, including Departments of Pharmacology and Neurology, Center for Neurodegenerative Disease, Comprehensive Neuroscience Institute, Chemical Biology Discovery Center, and Drug Discovery Institute, and facilitate the development of novel therapeutic approaches for treating neurodegenerative diseases. PUBLIC HEALTH RELEVANCE: Neurodegenerative diseases are becoming more common as the population ages, but currently there is no cure to stop the progression of these devastating illnesses. The plans described in this application will enhance Emory's multidisciplinary research capacity on the studies of neurodegenerative diseases and promote the development of new therapeutic strategies for combating neurodegeneration.

描述（由申请人提供）：该提案旨在通过生物医学研究核心中心（p30）机制，为埃默里大学在神经退行性疾病新治疗策略领域的新教师招聘提供支持。作为中心主任，Raymond Dingledine博士（主席和药理学教授和执行副院长在医学院的研究）将与艾伦利维博士（神经病学主席、教授、神经退行性疾病中心主任）和李连（副主席和药理学教授）招募和指导一个高度积极的任期-跟踪助理教授进行研究，重点是神经退行性疾病的基础和/或转化研究，与打击神经退行性疾病的新型治疗策略的发展相关。新招募的研究者将在药理学部门进行主要任命，并在神经内科和神经退行性疾病中心进行次要任命。核心中心将利用慷慨的机构支持空间，人员和其他资源，并提供一个优秀的，协作的，跨学科的环境和全面的，彻底的，严格的教师发展和评估计划，促进新教师的独立研究生涯和专业发展。实现本申请中提出的目标将增加和扩大埃默里大学多学科研究人员的社区，重点是神经退行性疾病的基础，转化和临床研究，建立和加强各组成部分之间的机构内关系，包括药理学和神经病学部门，神经退行性疾病中心，综合神经科学研究所，化学生物学发现中心，和药物发现研究所，并促进治疗神经退行性疾病的新治疗方法的开发。 公共卫生关系：随着人口老龄化，神经退行性疾病变得越来越普遍，但目前还没有治愈方法来阻止这些毁灭性疾病的进展。本申请中描述的计划将增强埃默里大学在神经退行性疾病研究方面的多学科研究能力，并促进新的治疗策略的发展，以对抗神经退行性疾病。